Citation Impact
Citing Papers
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Nicotine Chemistry, Metabolism, Kinetics and Biomarkers
2009 Standout
Plasma corticotrophin‐releasing factor (CRF) in abnormal pregnancy
1988
Pituitary growth hormone and placental lactogen levels measured in normal term pregnancy and at the early and late postpartum periods
1969
Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure
1996
Contraceptive failure in the United States
2011 Standout
Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: Results of a controlled, randomized, prospective study
1990
Insulin-Like Growth Factors I and II. Peptide, Messenger Ribonucleic Acid and Gene Structures, Serum, and Tissue Concentrations*
1989 Standout
Benefits and risks of menopausal estrogen and/or progestin hormone use
1988
FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography
2015 Standout
Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study
2004
The Heart and Estrogen/Progestin Replacement Study
1999
Effects of Progestin-Opposed Transdermal Estrogen Administration on Growth Hormone and Insulin-Like Growth Factor-I in Postmenopausal Women of Different Ages*
1991
The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin–angiotensin system in normotensive postmenopausal women
1999
Risks and Benefits of Nicotine to Aid Smoking Cessation in Pregnancy
2001
Placenta Previa, Placenta Accreta, and Vasa Previa
2006 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy
1993
Prevention of VTE in Nonsurgical Patients
2012 Standout
ESHRE guideline for the diagnosis and treatment of endometriosis
2005 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
A comparative study of the effects of gestodene 60 µg/ethinylestradiol 15 µg and desogestrel 150 µg/ethinylestradiol 20 µg on hemostatic balance, blood lipid levels and carbohydrate metabolism
1999
Salivary cortisol as a biomarker in stress research
2008 Standout
The Human Placental Lactogen Genes: Structure, Function, Evolution and Transcriptional Regulation
1991
Effect of oral contraceptives on adrenocorticotropin and growth hormone secretion following CRH and GHRH administration
1989
Clinical risk factors for placenta previa–placenta accreta
1997 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
The Effects of Oral Dehydroepiandrosterone on Endocrine-Metabolic Parameters in Postmenopausal Women*
1990
The effect of conjugated equine oestrogen on diabetes incidence: the Women’s Health Initiative randomised trial
2006
Diabetes Mellitus and Sperm Parameters
2012 Standout
Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial
2004
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus
2009
Contraception and the Risk of Type 2 Diabetes Mellitus in Latina Women With Prior Gestational Diabetes Mellitus
1998
Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
1991 Standout
Carbohydrate metabolism during hormonal substitution therapy
1989
Derivation of Functional Antagonists Using N-Terminal Extracellular Domain of Gonadotropin and Thyrotropin Receptors
1997 StandoutNobel
Polycystic ovary syndrome
2016 Standout
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Progestogen-only pills and high blood pressure: is there an association?
2004
Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial
2000
The influence of androgens on insulin resistance
1984
Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes
1986
Combination contraceptives: effects on weight
2014
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences
1997
Characterization of Groups of Hyperaiidrogenic Women with Acanthosis Nigricans, Impaired Glucose Tolerance, and/or Hyperinsulinemia*
1987 Standout
Criteria for screening tests for gestational diabetes
1982 Standout
Depo-medroxyprogesterone acetate as a contraceptive agent: Its effect on weight and blood pressure
1972
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Heterogeneity of radioligand binding to alpha-adrenergic receptors. Analysis of guanine nucleotide regulation of agonist binding in relation to receptor subtypes.
1980 StandoutNobel
Determinants of low birth weight: methodological assessment and meta-analysis.
1987 Standout
Oral Contraceptives and Cardiovascular Disease
1981
Uterine leiomyomata: etiology, symptomatology, and management
1981 Standout
Oral contraceptives and hypertension.
1988
Studies on the Mechanism of Increased Plasma Triglyceride Levels Induced by Oral Contraceptives
1969
Semen analyses in adolescent diabetic patients
1984
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
α adrenoreceptors but not β adrenoreceptors increase in rabbit uterus with oestrogen
1977 Nature
Retrospective Study of the Management of Childhood and Adolescent Gender Identity Disorder Using Medroxyprogesterone Acetate
2015
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Weight and body fat changes in postpartum depot-medroxyprogesterone acetate users
2012
Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial
2003
Effect of seven low-dose combined oral contraceptive preparations on carbohyrate metabolism
1987
Insulin resistance, secretion, and metabolism in users of oral contraceptives.
1992
Estrogen and Coronary Heart Disease in Women
1991 Standout
Effect of Oral Medroxyprogesterone Acetate on Menopausal Symptoms in Patients with Endometrial Carcinoma
1982
Absence of human placental lactogen in an otherwise uneventful pregnancy
1979
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences*
1997
Sex Differences and the Epidemiology of Depression
1977 Standout
Oral Contraceptives, Pyridoxine, and Depression
1973
The Metabolic Syndrome
2008 Standout
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Effects of maternal smoking on circulating catecholamine levels and fetal heart rates
1979
SOME EFFECTS OF ORAL CONTRACEPTIVES ON CARBOHYDRATE METABOLISM
1966
Direct Binding Studies of Adrenergic Receptors: Biochemical, Physiologic, and Clinical Implications
1979 StandoutNobel
Measurement in Medicine: The Analysis of Method Comparison Studies
1983 Standout
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
Contraceptive Failure in the United States: A Critical Review of the Literature
1987
Tubal Infertility and the Intrauterine Device
1985
Effects of long-term estrogen replacement therapy
1979
The conservative aggressive management of placenta previa
1980
Gestational Diabetes and the Incidence of Type 2 Diabetes
2002 Standout
Betamimetics for inhibiting preterm labour
2014
Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes
1987
MEASUREMENT OF THE LECITHIN/SPHINGOMYELIN RATIO AND PHOSPHATIDYLGLYCEROL IN AMNIOTIC FLUID: AN ACCURATE METHOD FOR THE ASSESSMENT OF FETAL LUNG MATURITY
1981
Carbohydrate metabolism in pregnancy
1969
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus
2014
Triphasic oral contraception: Metabolic effects in normal women and those with previous gestational diabetes
1985
Relation of Body Fat Distribution to Metabolic Complications of Obesity*
1982 Standout
Works of S.A. Birk being referenced
Human placental lactogen levels in multiple pregnancies.
1978
Carbohydrate Metabolic Studies After Six Cycles of Combined Type Oral Contraceptive Tablets: Measurement of Plasma Insulin and Blood Glucose Levels
1967
Carbohydrate Metabolism and the Semen Profile: Glucose, Insulin, and Sperm Studies
1979
The effect of smoking on serum human placental lactogen levels
1977
The acute effects of ritodrine infusion on maternal metabolism: Measurements of levels of glucose, insulin, glucagon, triglycerides, cholesterol, placental lactogen, and chorionic gonadotropin
1978
The Effect of Gonadotropin-Releasing Hormone on Blood Glucose, Insulin, Luteinizing Hormone, and Follicle-Stimulating Hormone Levels
1977
Medroxyprogesterone Acetate and Carbohydrate Metabolism: Measurement of Glucose, Insulin, and Growth Hormone During 6 Months’ Time
1970
Glucose and insulin alterations after one year of combination-type oral contraceptive treatment
1968
Dynamics of human placental lactogen
1966
Value of human chrionic somatomammotropin in managing high-risk pregnancies
1971
Carbohydrate metabolism studies in women using Brevicon, a low-estrogen type of oral contraceptive, for one year
1982
The effects of two years of mestranol treatment on carbohydrate metabolism
1982
Norgestrel and carbohydrate-lipid metabolism: Glucose, insulin and triglyceride changes during six months time of use
1974
The Development of Elevated Blood Pressure While Using Oral Contraceptives: A Preliminary Report of a Prospective Study
1970
THE EFFECT OF THE PROGESTOGEN ETHYNODIOL DIACETATE ON GLUCOSE, INSULIN, AND GROWTH HORMONE AFTER SIX MONTHS TREATMENT
1972
The Effects of Medroxyprogesterone Acetate on Carbohydrate Metabolism: Measurements of Glucose, Insulin, and Growth Hormone After Twelve Months’ Use
1972
Lipid and Carbohydrate Metabolic Studies After One Year of Megestrol Acetate Treatment
1976
Comparative randomized study of the Copper-T 200 and Dalkon Shield intrauterine devices
1975
The effect of estrogens on carbohydrate metabolism: Glucose, insulin, and growth hormone studies on one hundred and seventy-one women ingesting Premarin, mestranol, and ethinyl estradiol for six months
1972
Carbohydrate metabolism prospectively studied in women using a low-estrogen oral contraceptive for six months
1979
The Effect of Copper Intrauterine Devices on Endocervical Gonococcal Cultures
1974
The effects of vitamin B6 on carbohydrate metabolism in women taking steroid contraceptives: Preliminary report
1972
Carbohydrate metabolism with three months of low-estrogen contraceptive use
1980
Effect of estrogen treatment for one year on carbohydrate and lipid metabolism in women with normal and abnormal glucose tolerance test results
1978
Effects of norethindrone on carbohydrate and lipid metabolism.
1975
The effects of norgestrel on carbohydrate and lipid metabolism over one year
1976
Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive
1980
Respiratory distress syndrome with mature lecithin/sphingomyelin ratios: Diabetes mellitus and low Apgar scores
1976
The effect of intrauterine devices, oral contraceptives, estrogens, and progestogens on blood pressure
1972
The effectiveness of human placental lactogen measurements as an adjunct in decreasing perinatal deaths. Results of a retrospective and a randomized controlled prospective study.
1975
Prospective Studies of Carbohydrate Metabolism in “Normal” Women Using Norgestrel for Eighteen Months
1981
Carbohydrate and Lipid Metabolic Studies Before and after One Year of Treatment with Ethynodiol Diacetate in “Normal” Women
1976